Causes of death in Prader-Willi syndrome: lessons from 11 years' experience of a national reference center.


Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
04 11 2019
Historique:
received: 29 04 2019
accepted: 24 09 2019
entrez: 6 11 2019
pubmed: 7 11 2019
medline: 7 7 2020
Statut: epublish

Résumé

In the last 20 years, substantial improvements have been made in the diagnosis, treatment and management of patients with Prader-Willi syndrome (PWS). Few data on causes of death are available since those improvements were made. Our study assessed the causes of death among French patients with PWS over the first 11 years of experience of the nationwide French Reference Center for PWS (FRC-PWS). Our study relied on two sources of mortality information at national level between 2004 and 2014: The French Epidemiological Centre for the Medical Causes of Death (CépiDc) Registry and the FRC-PWS database. Causes of death were classified into seven categories: respiratory, cardiovascular, gastrointestinal, severe infection, sudden death, other causes, and unknown. Descriptive statistics were calculated separately for children (< 18 years-old) and adults (≥18 years-old). One hundred and four deaths were identified in France from 2004 to 2014. The median age at death was 30 years, ranging from less than 1 month to 58 years. Seventeen deaths occurred in patients under 18 years, with 70% of them in children under 2 years. Respiratory causes accounted for more than 50% of the deaths in patients with PWS in both children and adults. Both cause and age of death did not significantly differ according to gender or genetic subtype. Patients with PWS die prematurely due to a respiratory cause in most cases at all ages. In those adult patients with data on obesity, 98% were reported to be obese.

Sections du résumé

BACKGROUND
In the last 20 years, substantial improvements have been made in the diagnosis, treatment and management of patients with Prader-Willi syndrome (PWS). Few data on causes of death are available since those improvements were made. Our study assessed the causes of death among French patients with PWS over the first 11 years of experience of the nationwide French Reference Center for PWS (FRC-PWS).
METHODS
Our study relied on two sources of mortality information at national level between 2004 and 2014: The French Epidemiological Centre for the Medical Causes of Death (CépiDc) Registry and the FRC-PWS database. Causes of death were classified into seven categories: respiratory, cardiovascular, gastrointestinal, severe infection, sudden death, other causes, and unknown. Descriptive statistics were calculated separately for children (< 18 years-old) and adults (≥18 years-old).
RESULTS
One hundred and four deaths were identified in France from 2004 to 2014. The median age at death was 30 years, ranging from less than 1 month to 58 years. Seventeen deaths occurred in patients under 18 years, with 70% of them in children under 2 years. Respiratory causes accounted for more than 50% of the deaths in patients with PWS in both children and adults. Both cause and age of death did not significantly differ according to gender or genetic subtype.
CONCLUSIONS
Patients with PWS die prematurely due to a respiratory cause in most cases at all ages. In those adult patients with data on obesity, 98% were reported to be obese.

Identifiants

pubmed: 31684997
doi: 10.1186/s13023-019-1214-2
pii: 10.1186/s13023-019-1214-2
pmc: PMC6829836
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

238

Références

Am J Med Genet A. 2004 Jan 15;124A(2):158-64
pubmed: 14699614
Horm Res Paediatr. 2010;74(2):121-8
pubmed: 20395666
Diabetes Obes Metab. 2017 Dec;19(12):1751-1761
pubmed: 28556449
Arch Dis Child. 2017 Jul;102(7):634-638
pubmed: 28130217
Horm Res. 2005;63(1):29-32
pubmed: 15583479
Am J Med Genet A. 2015 Feb;167A(2):371-8
pubmed: 25424396
Sleep Med. 2011 Jun;12(6):591-7
pubmed: 21645873
Genet Med. 2018 Jan;20(1):24-30
pubmed: 28682308
J Child Psychol Psychiatry. 2017 Jan;58(1):64-74
pubmed: 27481444
Arch Dis Child. 2013 Aug;98(8):592-5
pubmed: 23761691
Horm Res. 2007;67(4):203-4
pubmed: 17164585
J Endocrinol Invest. 2005 Jun;28(6):554-7
pubmed: 16117198
J Clin Endocrinol Metab. 2013 Feb;98(2):E328-35
pubmed: 23284006
J Med Genet. 2001 Nov;38(11):792-8
pubmed: 11732491
J Clin Endocrinol Metab. 2008 Nov;93(11):4183-97
pubmed: 18697869
Int J Legal Med. 2005 May;119(3):153-7
pubmed: 15750809
J Pharmacol Exp Ther. 2018 May;365(2):301-313
pubmed: 29491038
J Clin Exp Cardiolog. 2013;Suppl 10(6):1-9
pubmed: 24027655
Am J Med Genet A. 2007 Mar 1;143A(5):484-7
pubmed: 17036318
Pediatr Obes. 2018 Jan;13(1):3-13
pubmed: 27863129
J Clin Endocrinol Metab. 2013 Jun;98(6):E1072-87
pubmed: 23543664
J Clin Sleep Med. 2014 Apr 15;10(4):403-9
pubmed: 24733986
Am J Med Genet A. 2008 Apr 1;146A(7):881-7
pubmed: 18324685
Clin Endocrinol (Oxf). 2010 Nov;73(5):686-8
pubmed: 20718763
Am J Med Genet A. 2011 May;155A(5):1040-9
pubmed: 21465655
Paediatr Respir Rev. 2017 Mar;22:52-59
pubmed: 27839656
Diseases. 2016 Jul 08;4(3):null
pubmed: 28933403
Genet Med. 2017 Jun;19(6):635-642
pubmed: 27854358
Am J Med Genet A. 2019 Feb;179(2):196-205
pubmed: 30569567
Am J Med Genet A. 2008 Apr 1;146A(7):861-72
pubmed: 18203198
J Obes. 2012;2012:473941
pubmed: 23133744
J Pediatr. 2003 Feb;142(2):174-8
pubmed: 12584540
Am J Med Genet A. 2005 Jul 1;136(1):45-8
pubmed: 15937939
J Paediatr Child Health. 2012 Jun;48(6):506-11
pubmed: 22697408
Respir Physiol Neurobiol. 2009 Aug 31;168(1-2):119-24
pubmed: 19712904
Sleep. 2017 Dec 1;40(12):
pubmed: 29294134
Am J Med Genet A. 2004 Feb 1;124A(4):333-8
pubmed: 14735579
Eur J Pediatr. 2016 Jan;175(1):9-18
pubmed: 26584571
Genet Med. 2012 Jan;14(1):10-26
pubmed: 22237428
J Endocrinol Invest. 2015 Dec;38(12):1249-63
pubmed: 26062517
BMC Med Genet. 2008 Oct 02;9:89
pubmed: 18831731
Medicine (Baltimore). 2017 Dec;96(50):e9256
pubmed: 29390364
N Engl J Med. 2009 Jan 15;360(3):225-35
pubmed: 19144938
Orphanet J Rare Dis. 2017 Jun 28;12(1):118
pubmed: 28659150
Biol Neonate. 2002 Aug;82(2):139-41
pubmed: 12169838
Am J Ment Retard. 2006 May;111(3):193-8
pubmed: 16597186
Horm Res. 2008;69(1):45-52
pubmed: 18059083
Eur J Hum Genet. 2004 Mar;12(3):238-40
pubmed: 14679397
Horm Res. 2005;63(1):33-9
pubmed: 15604598

Auteurs

Dibia Liz Pacoricona Alfaro (DL)

UMR 1027 Inserm- Paul Sabatier University, Toulouse, France.

Perrine Lemoine (P)

Endocrinology, Obesity, Bone Diseases, Genetics and Gynecology Unit, Children's Hospital, University Hospital Center of Toulouse, Toulouse, France.

Virginie Ehlinger (V)

UMR 1027 Inserm- Paul Sabatier University, Toulouse, France.

Catherine Molinas (C)

Endocrinology, Obesity, Bone Diseases, Genetics and Gynecology Unit, Children's Hospital, University Hospital Center of Toulouse, Toulouse, France.
French National Reference Center for Prader-Willi Syndrome, Children's Hospital, University Hospital Center of Toulouse, 330, avenue de Grande-Bretagne - TSA 40031, 31059, Toulouse cedex 9, France.
Centre de Physiopathologie de Toulouse-Purpan, UMR 5282 CNRS, UMR 1043 Inserm, Paul Sabatier University, Toulouse, France.

Gwénaëlle Diene (G)

UMR 1027 Inserm- Paul Sabatier University, Toulouse, France.
Endocrinology, Obesity, Bone Diseases, Genetics and Gynecology Unit, Children's Hospital, University Hospital Center of Toulouse, Toulouse, France.
French National Reference Center for Prader-Willi Syndrome, Children's Hospital, University Hospital Center of Toulouse, 330, avenue de Grande-Bretagne - TSA 40031, 31059, Toulouse cedex 9, France.

Marion Valette (M)

Endocrinology, Obesity, Bone Diseases, Genetics and Gynecology Unit, Children's Hospital, University Hospital Center of Toulouse, Toulouse, France.
French National Reference Center for Prader-Willi Syndrome, Children's Hospital, University Hospital Center of Toulouse, 330, avenue de Grande-Bretagne - TSA 40031, 31059, Toulouse cedex 9, France.

Graziella Pinto (G)

Pediatric Endocrinology, Diabetology and Gynecology Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Necker Children's University Hospital, Paris, France.

Muriel Coupaye (M)

French National Reference Center for Prader-Willi Syndrome, Nutrition Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, Paris, France.

Christine Poitou-Bernert (C)

French National Reference Center for Prader-Willi Syndrome, Nutrition Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, Paris, France.
Nutriomics team, Sorbonne University, UPMC University Paris 06, Inserm, Paris, France.

Denise Thuilleaux (D)

French National Reference Center for Prader-Willi Syndrome, Prader-Willi Unit, Assistance Publique Hôpitaux de Paris (AP-HP), Marine Hendaye Hospital, Hendaye, France.

Catherine Arnaud (C)

UMR 1027 Inserm- Paul Sabatier University, Toulouse, France.
Unité de Soutien Méthodologique à la Recherche, University Hospital Center of Toulouse, Toulouse, France.

Maithé Tauber (M)

Endocrinology, Obesity, Bone Diseases, Genetics and Gynecology Unit, Children's Hospital, University Hospital Center of Toulouse, Toulouse, France. tauber.mt@chu-toulouse.fr.
French National Reference Center for Prader-Willi Syndrome, Children's Hospital, University Hospital Center of Toulouse, 330, avenue de Grande-Bretagne - TSA 40031, 31059, Toulouse cedex 9, France. tauber.mt@chu-toulouse.fr.
Centre de Physiopathologie de Toulouse-Purpan, UMR 5282 CNRS, UMR 1043 Inserm, Paul Sabatier University, Toulouse, France. tauber.mt@chu-toulouse.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH